These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30078801)

  • 21. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
    Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
    Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.
    Ding Y; Zhang B; Payne JL; Song C; Ge Z; Gowda C; Iyer S; Dhanyamraju PK; Dorsam G; Reeves ME; Desai D; Huang S; Payne KJ; Yue F; Dovat S
    Leukemia; 2019 Nov; 33(11):2720-2731. PubMed ID: 31073152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Super-Enhancers Dysregulations in Hematological Malignancies.
    Belloucif Y; Lobry C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S1P-S1PR3-RAS promotes the progression of S1PR3
    Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
    Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
    Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory network analysis reveals the oncogenesis roles of feed-forward loops and therapeutic target in T-cell acute lymphoblastic leukemia.
    Xia M; Zhang Q; Luo M; Li P; Wang Y; Lei Q; Guo AY
    BMC Med Genomics; 2019 Jan; 12(1):8. PubMed ID: 30646895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
    Smith C; Touzart A; Simonin M; Tran-Quang C; Hypolite G; Latiri M; Andrieu GP; Balducci E; Dourthe MÉ; Goyal A; Huguet F; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Plass C; Ghysdael J; Boissel N; Asnafi V
    Mol Cancer; 2023 Jan; 22(1):12. PubMed ID: 36650499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.
    Balbach ST; Makarova O; Bonn BR; Zimmermann M; Rohde M; Oschlies I; Klapper W; Rössig C; Burkhardt B
    Leukemia; 2016 Apr; 30(4):970-3. PubMed ID: 26216196
    [No Abstract]   [Full Text] [Related]  

  • 29. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.
    Ong JZL; Yokomori R; Wong RWJ; Tan TK; Ueda R; Ishida T; Iida S; Sanda T
    Leukemia; 2022 Sep; 36(9):2293-2305. PubMed ID: 35908104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
    Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
    Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
    Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
    Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
    Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
    Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
    Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
    Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
    Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
    Jenkins CE; Gusscott S; Wong RJ; Shevchuk OO; Rana G; Giambra V; Tyshchenko K; Islam R; Hirst M; Weng AP
    Exp Hematol; 2018 Aug; 64():84-96. PubMed ID: 29733873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers.
    Sugino N; Kawahara M; Tatsumi G; Kanai A; Matsui H; Yamamoto R; Nagai Y; Fujii S; Shimazu Y; Hishizawa M; Inaba T; Andoh A; Suzuki T; Takaori-Kondo A
    Leukemia; 2017 Nov; 31(11):2303-2314. PubMed ID: 28210006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
    Khan A; Mathelier A; Zhang X
    Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia.
    Islam R; Jenkins CE; Cao Q; Wong J; Bilenky M; Carles A; Moksa M; Weng AP; Hirst M
    iScience; 2023 Jun; 26(6):106795. PubMed ID: 37213235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tumor Suppressor Enhancer of
    Tottone L; Lancho O; Loh JW; Singh A; Kimura S; Roels J; Kuchmiy A; Strubbe S; Lawlor MA; da Silva-Diz V; Luo S; Gachet S; García-Prieto CA; Hagelaar R; Esteller M; Meijerink JPP; Soulier J; Taghon T; Van Vlierberghe P; Mullighan CG; Khiabanian H; Rocha PP; Herranz D
    Blood Cancer Discov; 2021 Jan; 2(1):92-109. PubMed ID: 33458694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.